lobbying_activities: 1849253

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1849253	eb0deac6-ddca-4a1b-9b37-d9a488dc84d7	Q2	BROWN RUDNICK LLP	287895	AMNEAL PHARMACEUTICALS	2016	second_quarter	PHA	HR 4981 -Opioid Use Disorder Treatment Expansion and Modernization Act; HR 4976 - Opioid Review Modernization Act of 2016; S. 524 Comprehensive Addiction and Recovery Act (CARA)	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2016-07-19T10:45:48-04:00